LILLY FDA Approval NDA 020101

NDA 020101

LILLY

FDA Drug Application

Application #020101

Documents

Letter2005-02-23
Letter2008-03-24
Label2006-09-21
Label2007-08-03
Label2008-03-24
Review2004-08-09
Letter2004-06-01
Letter2004-08-25
Letter2005-12-05
Letter2006-04-13
Letter2007-03-23
Letter2007-08-07
Letter2008-03-12
Letter2009-02-03
Label2008-03-13
Label2009-02-04
Other Important Information from FDA2005-08-01

Application Sponsors

NDA 020101LILLY

Marketing Status

Discontinued001

Application Products

001SOLUTION;ORALEQ 20MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1PROZACFLUOXETINE HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1991-04-24PRIORITY
LABELING; LabelingSUPPL2AP1992-01-21PRIORITY
LABELING; LabelingSUPPL3AP1992-08-20PRIORITY
LABELING; LabelingSUPPL4AP1993-08-18PRIORITY
LABELING; LabelingSUPPL5AP1993-03-25PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1995-05-22PRIORITY
LABELING; LabelingSUPPL7AP1994-07-06PRIORITY
LABELING; LabelingSUPPL9AP1997-03-25PRIORITY
LABELING; LabelingSUPPL10AP1995-03-01PRIORITY
LABELING; LabelingSUPPL11AP1995-09-12PRIORITY
LABELING; LabelingSUPPL12AP1995-09-12PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1996-04-01PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1998-04-23PRIORITY
LABELING; LabelingSUPPL21AP1998-03-13PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1998-08-04PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1998-08-04PRIORITY
LABELING; LabelingSUPPL24AP1999-10-07PRIORITY
LABELING; LabelingSUPPL26AP1999-06-16PRIORITY
EFFICACY; EfficacySUPPL27AP2002-07-29PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2004-05-25PRIORITY
LABELING; LabelingSUPPL31AP2004-08-19PRIORITY
LABELING; LabelingSUPPL32AP2005-12-01PRIORITY
LABELING; LabelingSUPPL33AP2005-02-18PRIORITY
LABELING; LabelingSUPPL34AP2006-04-11PRIORITY
LABELING; LabelingSUPPL35AP2006-09-20PRIORITY
LABELING; LabelingSUPPL36AP2007-03-15PRIORITY
LABELING; LabelingSUPPL37AP2007-08-02PRIORITY
LABELING; LabelingSUPPL38AP2008-03-09PRIORITY
LABELING; LabelingSUPPL39AP2008-03-21PRIORITY
LABELING; LabelingSUPPL42AP2009-01-30PRIORITY

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL14Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL26Null0
SUPPL27Null0
SUPPL29Null0
SUPPL31Null0
SUPPL32Null0
SUPPL33Null0
SUPPL34Null0
SUPPL35Null0
SUPPL36Null0
SUPPL37Null0
SUPPL38Null0
SUPPL39Null0
SUPPL42Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20101
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.